Rx Processing Announces William A. Folino New VP of Sales and Marketing

Signs Three Year Employment Agreement


TAMPA, Fla., Feb. 10, 2005 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), a leading source of low-cost prescription medications for millions of Americans who have no prescription insurance coverage, announces William A. Folino as New Vice President of Sales and Marketing. Mr. Folino, as director of Sales and Marketing since September, has focused on developing a strategic marketing and sales approach to target large market growth areas including assisted living facilities, managed care insurance groups, and large employee unions, while increasing the number of sales affiliates; he is personally responsible for signing three new sales affiliates this week. The twenty-four years of experience with major industry leaders, including 13 years at SmithKline Beecham/Quest Diagnostics and Roche Bio-Medical/Lab Corp. of America, has earned him the respect of the industry.

William Folino, VP Sales and marketing, stated, "I will lead Rx Processing Corp. focused on harnessing the synergies while I solidify the offerings of Prescription Drugs, Lab Testing and Drug Screenings. The company principles of Assurances, Compliance, Efficacy, and Safety will at all times guide me in developing sales and marketing practices."

Peter Matuch, President of Lab Services Division, recently stated, "By providing early detection screening and access to low cost prescriptions together under one company, we will be providing unmatched affordable healthcare solutions for the uninsured -- this creates a win-win situation for all people that learn about and order through Rx Processing Corp. I have decided to continue working with Rx Processing Corp. under a three-year employment contract where my salary is tied to achieving results as we continue to build new clients and provide our members access to affordable lab screenings and prescription drugs."

Peter Fiorillo, CEO of Rx Processing commented, "I feel privileged to have William Folino as the company's Vice President of Sales and Marketing. He is a proven sales leader in the clinical pathology laboratory service industry and pharmaceutical sales. William Folino is a visionary that has taken the action to develop the connections for the synergistically perfect combination of laboratory service and prescription drugs. I recognize him as the visionary that saw the synergistic combination for Rx Processing Corp to provide the uninsured access to both. He has proven his commitment and carried his actions to the highest levels of integrity, guided by his principles and devotion to individual's health care needs. I welcome him to the team."

Americans who have no prescription insurance coverage or lab testing coverage have turned to Rx Processing, which offers FDA-approved American generic and low-cost Canadian brand name drugs with access to over 3,000 FDA-approved patient service centers for their lab testing. Rx Processing's state-of-the-art technology finds the best prescription drug prices for these customers and members by sending their prescriptions to licensed pharmacies or lab order to the closest patient center to be serviced. Rx Processing provides access to prescription drugs, lab testing and drug testing for the 40 million Americans without prescription drug coverage who spend billions of dollars on their prescription drugs, lab testing and drug testing per year.

Rx Processing is rapidly becoming a market leader in providing prescription drugs, lab tests and Drug tests to U.S. Citizens, corporations, unions, and members through FDA-approved patient service centers for their Lab testing and licensed pharmacies in the United States and Canada. The Company provides access to over 1,500 approved brand name and generic medications and provides access to over 1,000 diagnostic tests including: heart disease risk assessment, cancer detection and several other wellness tests and early detection diagnostics ready for distribution an service in the U.S. market through its Company owned and operated storefront locations and over 130 affiliated storefronts with access to 3,000 FDA-approved patient service centers. By utilizing Rx Processing, U.S. citizens can save up to 84% on their daily prescriptions up to 50% on their lab testing and drugs screening. Ordering these reduced cost medications and lab tests are available at the Company's affiliate retail storefronts and information about the company can be found at www.rxprocessingcorp.com.

Safe Harbor Statement

All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.



            

Contact Data